JPRN-UMIN000010291
Recruiting
Phase 2
Efficacy of transcatheter arterial chemoembolization (TACE) with miriplatin for multiple hepatocellular carcinoma refractory or inappropriate to conventional TACE - Efficacy of transcatheter arterial chemoembolization (TACE) with miriplatin for multiple hepatocellular carcinoma refractory or inappropriate to conventional TACE
Department of Surgery, Graduate School of Medicine Kyoto University0 sites20 target enrollmentApril 1, 2013
ConditionsMultiple hepatocellular carcinoma
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Multiple hepatocellular carcinoma
- Sponsor
- Department of Surgery, Graduate School of Medicine Kyoto University
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with another active cancer 2\) Patients with extrahepatic metastasis 3\) Patients with prior surgical reconstruction of the biliary tract or prior endoscopic treatment of ampulla of vater 4\) Patients with clinically significant refractory ascites or pleural effusion 5\) Patients with hepatic encephalopathy 6\) Patients with severe co\-morbidity such as cardiac failure and renal failure 7\) Patients with a medical history of severe hypersensitivity 8\) Patients who are pregnant, lactating or are suspected to be pregnant. 9\) Patients who are concluded to be inappropriate to participate in this study by their physicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effectiveness of transcatheter arterial embolization for patients with shock from abdominopelvic traumaTranscatheter arterial embolization for patients with shock from abdominopelvic trauma was unclearTranscatheter arterial embolization,abdominopelvic trauma,hypovolemic shockTCTR20200312005/A14
Completed
Phase 2
Efficacy and safety of transarterial chemoembolization + vitamin K combination treatment against hepatocellular carcinoma-Open label, randomized, phase 2 studyJPRN-UMIN000026404Osaka General Medical Center101
Recruiting
Phase 1
Efficacy and safety of transcatheter arterial chemoembolization using combination of epirubicin and miriplatin for hepatocellular carcinoma -Prospective comparative study with transcatheter arterial chemoembolization using epirubicinHepatocellular carcinomaJPRN-UMIN000009149Kansai Medical University60
Recruiting
Phase 4
A clinical study to evaluate the effect of cTACE with Lipiodol in treatment of HCC patientsHealth Condition 1: C220- Liver cell carcinomaCTRI/2020/10/028544GUERBET
Completed
Not Applicable
Efficacy of Transcatheter Arterial Embolization Versus Open Abdomen in Intra-Abdominal Bleeding due to Duodenal Fistulapatients diagnosed with intra-abdominal bleeding due to duodenal fistulaopen abdomentranscatheter arterial embolizationintra-abdominal bleedingduodenal fistulaoutcomesTCTR20220320001Jinling Hospital151